Atrial Fibrillation

Latest News

Praxbind Gains Full FDA Approval as Pradaxa Reversal Agent

Praxbind Gains Full FDA Approval as Pradaxa Reversal Agent

Complete reversal was seen within 4 hours in the majority of patients, as measured by ecarin clotting time (ECT 82%) or diluted thrombin time (dTT 99%). In addition, there was a low late of thrombotic events and no new safety events were reported.

Pulmonary Arterial Hypertension Outcomes With Atrial Arrhythmia

Pulmonary Arterial Hypertension Outcomes With Atrial Arrhythmia

Increased right atrial and pulmonary wedge pressures and increased thyroid disease prevalence were associated with atrial arrhythmia development in idiopathic or systemic sclerosis-related pulmonary arterial hypertension.

Influenza Vaccination May Reduce Mortality Risk in Heart Failure

Influenza Vaccination May Reduce Mortality Risk in Heart Failure

A meta-analysis sought to determine the effect of influenza vaccination on cardiac-related mortality in patients with heart failure.

Targeting Underlying Conditions May Improve Sinus Rhythm in Atrial Fibrillation

Targeting Underlying Conditions May Improve Sinus Rhythm in Atrial Fibrillation

Patients with persistent atrial fibrillation who received targeted therapy saw improvements in sinus rhythm as well as reductions in blood pressure, cholesterol, and weight.

Atrial Fibrillation Treated With LAA Occlusion Reduces Thromboembolism Risk

Atrial Fibrillation Treated With LAA Occlusion Reduces Thromboembolism Risk

Surgical left atrial appendage occlusion is associated with a lower risk for thromboembolism-related hospital readmission in older patients with atrial fibrillation who undergo cardiac surgery.

Ischemic Stroke Risk in Atrial Flutter vs Fibrillation

Ischemic Stroke Risk in Atrial Flutter vs Fibrillation

Patients with atrial fibrillation have a higher risk for ischemic stroke compared with patients with atrial flutter.

Measuring Cost-Effectiveness of DOACs, Warfarin for Stroke Prevention

Measuring Cost-Effectiveness of DOACs, Warfarin for Stroke Prevention

Cost-effective DOACs like apixaban prevent strokes better than warfarin in patients with atrial fibrillation.

Bleeding Risk, Stroke Outcomes With Edoxaban vs Enoxaparin-Warfarin for Cardioversion of Atrial Fibrillation

Bleeding Risk, Stroke Outcomes With Edoxaban vs Enoxaparin-Warfarin for Cardioversion of Atrial Fibrillation

In patients with atrial fibrillation at high risk for stroke, edoxaban is associated with lower rates of cardiovascular death events.

Short-Run Atrial Tachyarrhythmia Associated With Increased Stroke Risk

Short-Run Atrial Tachyarrhythmia Associated With Increased Stroke Risk

Patients who had short-run atrial tachyarrhythmia experienced significantly higher rates of stroke compared with patients who did not have short-run atrial tachyarrhythmia.

Renal Function Outcomes in Atrial Fibrillation With Oral Anticoagulation Therapy

Renal Function Outcomes in Atrial Fibrillation With Oral Anticoagulation Therapy

Patients with atrial fibrillation who are treated with oral anticoagulants often experience renal function decline.

Latest Features

Digital Adherence Devices: Preventing Strokes in Afib One Reminder at a Time

Digital Adherence Devices: Preventing Strokes in Afib One Reminder at a Time

Using digital adherence devices to improve medication adherence in patients with atrial fibrillation may reduce the rate of ischemic strokes.

"Lone" Atrial Fibrillation: Lifestyle Management and Hybrid Procedures

"Lone" Atrial Fibrillation: Lifestyle Management and Hybrid Procedures

Optimal treatment strategies for lone atrial fibrillation have been unclear, but more technological advances and understanding of disease are propelling researchers forward.

"Lone" Atrial Fibrillation: Finding Optimal Treatment Strategies

"Lone" Atrial Fibrillation: Finding Optimal Treatment Strategies

Optimal treatment strategies for lone atrial fibrillation have been unclear, but more technological advances and understanding of disease are propelling researchers forward.

Atrial Fibrillation: Updates in Screening, Surgical Ablation, and Anticoagulation Use

Atrial Fibrillation: Updates in Screening, Surgical Ablation, and Anticoagulation Use

Anticoagulation under- and overdoing can be problematic in patients with atrial fibrillation.

Weighing Benefits and Risks of Anticoagulation in the Elderly

Weighing Benefits and Risks of Anticoagulation in the Elderly

Determining which patients who have atrial fibrillation should receive anticoagulation therapy for stroke prophylaxis can be challenging.

Oral Anticoagulants After Intracranial Hemorrhage Reduced Mortality Risk in Afib

Oral Anticoagulants After Intracranial Hemorrhage Reduced Mortality Risk in Afib

A declining trend in ischemic events was associated with oral anticoagulant therapy after intracranial hemorrhage.

ACC/AHA Issue Revised Performance and Quality Measures for Atrial Fibrillation

ACC/AHA Issue Revised Performance and Quality Measures for Atrial Fibrillation

New ACC/AHA performance and quality measures for atrial fibrillation/flutter include metrics for outpatient care.

Cryoablation vs Radiofrequency Ablation in Atrial Fibrillation

Cryoablation vs Radiofrequency Ablation in Atrial Fibrillation

Experts weigh in on cryoablation vs radiofrequency ablation techniques for atrial fibrillation in light of FIRE and ICE trial results.

Left Atrial Appendage Closure: Exciting New Proposition or a Practically Non-Feasible Alternative?

Left Atrial Appendage Closure: Exciting New Proposition or a Practically Non-Feasible Alternative?

Occlusion of the left atrial appendage provides protection against thromboembolic stroke in patients with nonvalvular atrial fibrillation.

Factors Affecting Choice of Non-Vitamin K Antagonist Oral Anticoagulants

Factors Affecting Choice of Non-Vitamin K Antagonist Oral Anticoagulants

Choosing the right anticoagulant agent can be a challenge for many reasons, including cost, familiarity, drug interactions, and reversibility.

Sign Up for Free e-Newsletters